Itraconazole Pellets Suppliers & Bulk Manufacturers
Available Forms: Pellets
Available Strengths: 100 mg or 200 mg
Reference Brands: Sporanox
Category:
Active Pharmaceutical Ingredient
Itraconazole pellets inhibit fungal enolase enzyme, disrupting energy production and cell wall synthesis. They are effective against systemic fungi like aspergillosis and histoplasmosis. Benefits include excellent bioavailability, broad-spectrum antifungal activity, and improved treatment of invasive mycoses, supporting faster recovery and disease management.
Itraconazole Pellets is available in Pellets
and strengths such as 100 mg or 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Itraconazole Pellets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Itraconazole Pellets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Itraconazole pellets API is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves validation, safety testing, and clinical validation. In the EU, CE marking certifies conformity under MDR regulations. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality itraconazole pellet APIs vital for treating systemic fungal infections worldwide, supporting effective disease management and patient outcomes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing